scholarly journals Angiogenic gene therapy in patients with nonrevascularizable ischemic heart disease: a phase 2 randomized, controlled trial of AdVEGF121 (AdVEGF121) versus maximum medical treatment

Gene Therapy ◽  
2006 ◽  
Vol 13 (21) ◽  
pp. 1503-1511 ◽  
Author(s):  
D J Stewart ◽  
◽  
J D Hilton ◽  
J M O Arnold ◽  
J Gregoire ◽  
...  
2014 ◽  
Vol 176 (2) ◽  
pp. 367-374 ◽  
Author(s):  
Puja K. Mehta ◽  
Donna M. Polk ◽  
Xiao Zhang ◽  
Ning Li ◽  
Jeannette Painovich ◽  
...  

2000 ◽  
Vol 15 (10) ◽  
pp. 685-693 ◽  
Author(s):  
Matthew W. Morgan ◽  
Raisa B. Deber ◽  
Hilary A. Llewellyn-Thomas ◽  
Peter Gladstone ◽  
R. J. Cusimano ◽  
...  

Author(s):  
John M. Mandrola ◽  
Sanjay Kaul ◽  
Andrew Foy

AbstractFour recently published randomized controlled trials have informed the care of patients with stable ischemic heart disease. The purpose of this clinical focus article is to offer a summary and critical appraisal of the recent evidence. We aim to aid clinicians in the translation of the trial evidence to patient care.


Sign in / Sign up

Export Citation Format

Share Document